Skip to content 
Her public comments changed considerably between the early and later stages of the story. In 2002, she was discussing fear, treatment uncertainty and the belief that hepatitis C could threaten her future. By 2005 and 2010, she was describing regular medical monitoring while still living with the virus. In 2015, the conversation shifted toward new medication and the possibility of a cure. Finally, she was able to announce that treatment had succeeded. Those different stages show how both an individual health condition and the medicine surrounding it can evolve across time.
The 12-week duration of Anderson’s eventual treatment was particularly striking compared with how long hepatitis C had affected her psychologically. She had carried the diagnosis for well over a decade, yet the medication that finally cleared the infection required only a fraction of that time. This did not mean the previous years disappeared or that the condition had never posed a health risk. Instead, it demonstrated the effectiveness of a new generation of antiviral treatment. The medical technology available to her in 2015 was fundamentally different from what she had encountered when she first asked how hepatitis C could be eliminated. That transformation is central to understanding why her story changed so dramatically.
Access was another issue Anderson herself emphasized when announcing her recovery. She celebrated being cured but simultaneously expressed concern about whether other patients could qualify for or afford treatment. Early direct-acting antiviral therapies were highly effective but initially generated considerable discussion about cost and access. The medical value of a cure is greatest when people can actually receive the medication. WHO continues to identify access to diagnosis and treatment as an important global challenge even though highly effective medicines now exist. In its 2026 hepatitis C fact sheet, WHO estimated that tens of millions of people worldwide were still living with chronic HCV infection.